Further, Tso et al. [12] showed that serum FABP4 was independently related to stroke (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.50–2.94; P < 0.001), and a high serum level was associated with increased risk of 3-month mortality in ischemic stroke subjects (OR 2.65, 95% CI 1.18–5.96; P = 0.018). Here, FABP4 is linked to stroke disorder.